Literature DB >> 12118376

Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.

Dana King1, Genyan Yang, Mary Ann Thompson, Scott W Hiebert.   

Abstract

Inactivation of the neurofibromatosis-1 (NF1) gene de-regulates RAS and cooperates with mutation or loss of the p53 tumor suppressor to induce tumorigenesis. p19(ARF) acts upstream of p53 in an oncogene checkpoint to induce apoptosis in response to activated RAS and other factors that stimulate proliferation. Therefore, we bred p19(ARF-/-) to NF1(+/-) mice to determine if loss of these genes collaborates in tumorigenesis. As expected from the embryonic lethality of NF1 null mice, no mice lacking both p19(ARF) and NF1 were born. Unexpectedly, the loss of one allele of NF1 did not greatly shorten the time to tumor formation in a p19(ARF) null background. The tumor types observed were characteristic of p19(ARF) null animals, not those associated with neurofibromatosis or those observed with NF1(+/-)/p53(+/-) mice. However, seven out of 12 animals developed multiple tumors, some with metastases. This multiple tumor phenotype was not previously observed with p19(ARF)-null mice and suggests a distinct form of cooperation between the loss of these tumor suppressors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118376     DOI: 10.1038/sj.onc.1205632

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.

Authors:  Stephen M Wiesner; Jennifer L Geurts; Miechaleen D Diers; Rachel J Bergerson; Diane E Hasz; Kelly J Morgan; David A Largaespada
Journal:  Am J Hematol       Date:  2011-07       Impact factor: 10.047

Review 3.  Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.

Authors:  Nicole M Brossier; Steven L Carroll
Journal:  Brain Res Bull       Date:  2011-08-10       Impact factor: 4.077

4.  NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.

Authors:  Rebecca D Dodd; Jeffrey K Mito; William C Eward; Rhea Chitalia; Mohit Sachdeva; Yan Ma; Jordi Barretina; Leslie Dodd; David G Kirsch
Journal:  Mol Cancer Ther       Date:  2013-07-15       Impact factor: 6.261

5.  Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.

Authors:  Steven D Rhodes; Yongzheng He; Abbi Smith; Li Jiang; Qingbo Lu; Julie Mund; Xiaohong Li; Waylan Bessler; Shaomin Qian; William Dyer; George E Sandusky; Andrew E Horvai; Amy E Armstrong; D Wade Clapp
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

6.  Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.

Authors:  Genyan Yang; Waleed Khalaf; Louis van de Locht; Joop H Jansen; Meihua Gao; Mary Ann Thompson; Bert A van der Reijden; David H Gutmann; Ruud Delwel; D Wade Clapp; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 7.  The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.

Authors:  Steven L Carroll
Journal:  Am J Pathol       Date:  2015-12-28       Impact factor: 4.307

8.  A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene.

Authors:  Bin Yin; Ruud Delwel; Peter J Valk; Margaret R Wallace; Mignon L Loh; Kevin M Shannon; David A Largaespada
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

9.  The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.

Authors:  Nancy M Joseph; Jack T Mosher; Johanna Buchstaller; Paige Snider; Paul E McKeever; Megan Lim; Simon J Conway; Luis F Parada; Yuan Zhu; Sean J Morrison
Journal:  Cancer Cell       Date:  2008-02       Impact factor: 31.743

10.  Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation.

Authors:  Angela C Hirbe; Sonika Dahiya; Dinorah Friedmann-Morvinski; Inder M Verma; D Wade Clapp; David H Gutmann
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.